Back
Outset Medical Vs. Perspective Therapeutics Industry Stock Comparison
Buy
55
OM
Outset Medical
Last Price:
3.27
Seasonality Move:
-24.15%
Buy
67
CATX
Perspective Therapeutics
Last Price:
1.79
Seasonality Move:
3.58%
Buy
55
Outset Medical (OM)
is a Buy
Is Outset Medical a Buy, Sell or Hold?
- The current Outset Medical [OM] share price is $4.13. The Score for OM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- OM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.76. The Score for CATX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OM Stock Price Chart
What is Outset Medical's stock price today?
-
The Outset Medical share price today is $4.13
The current trend is moderately bullish and OM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight selling pressure.
OM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 80.84 | Buy |
| Chaikin Money Flow: | 1530266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 3.15) | Buy |
| Bollinger Bands (100): | (2.18 - 4.62) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 64.38 | Buy |
| Chaikin Money Flow: | -1020082 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.46 - 1.72) | Buy |
| Bollinger Bands (100): | (0.56 - 1.44) | Buy |
OM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.23 | Buy |
| 20-day SMA: | 2.66 | Buy |
| 50-day SMA: | 2.52 | Buy |
| 200-day SMA: | 6.58 | Sell |
| 8-day EMA: | 3.38 | Buy |
| 20-day EMA: | 2.89 | Buy |
| 50-day EMA: | 2.83 | Buy |
| 200-day EMA: | 6.93 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.37 | Buy |
| 200-day SMA: | 0.67 | Buy |
| 8-day EMA: | 1.75 | Buy |
| 20-day EMA: | 1.64 | Buy |
| 50-day EMA: | 1.39 | Buy |
| 200-day EMA: | 0.85 | Buy |
Outset Medical Earnings Growth & OM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.28 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Outset Medical Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||